COWEN FINANCIAL PRODUCTS LLC

Company

Tarsus Pharmaceuticals, Inc.

Filed

May 5, 2023

Accession Number

0001085146-23-002078

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →